View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
May 31, 2022

Vitestro launches autonomous device for blood collection

The venipunture device helps empower patients to be self-efficacious during blood collection procedures.

Dutch medical robotics company Vitestro has revealed an advanced autonomous blood drawing device.

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

The new device combines artificial intelligence (AI) and ultrasound-guided 3D reconstruction with robotic needle insertion to ensure the precise and secure collection of blood.

The blood drawing device is intuitive to use and empowers patients to be self-efficacious during the complete blood collection procedure.

It allows almost full automation of the pre-analytical phase of the process.

The laboratory automation technology has the potential to reduce high blood test error rates, which are mainly caused by manual variability.

Vitestro said that it has already performed 1,500 automated blood draws in more than 1,000 patients with its prototype in clinical studies.

Vitestro co-founder and CEO Toon Overbeeke said: “The mounting shortage of healthcare personnel is imminent.

“The pandemic has further led to a loss of workforce, causing a bleak outlook for hospital output around the globe, and leading to reduced access and continuity of care.

“That’s why revolutionary automation like our blood drawing device is inevitable to solve the industry’s biggest problem.”

Initially, the company plans to implement the new device in outpatient phlebotomy departments, where patients can choose the new venipunture device or standard methods.

The technology can be used by patients aged 16 years and above, as well as those with comorbidities or puncture difficulty.

Vitestro plans to begin a pivotal clinical trial of the new device for regulatory approval in Europe from 2023 and expects to bring it to the European market in 2024.

According to the company, blood collection, known as phlebotomy, is the most common invasive medical procedure.

The automation of labour-intensive procedures can help to transform the quality and availability of care.

Related Companies

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network